Patients solely undergoing surgical release of their trigger finger had significantly higher odds and expedited rate of developing new-onset Dupuytren disease overall and undergoing subsequent treatment by fasciectomy compared with trigger fingers managed by other interventions.ĭupuytren contracture Dupuytren disease stenosing tenosynovitis trigger finger. Changes since 6.0b1: Feeds list: when dragging feeds/folders from one account to another, the operation is now always copy, to avoid data loss due to misunderstanding that moving a feed between accounts does not move its read/starred. 0005) more quickly than all other cohorts. If you’re already running a 6.0 test build, you can check for updates (be sure your prefs are set for test builds). 02) and underwent fasciectomy (mean, 49.74 days SD, 62.27 days log-rank P <. Trigger fingers managed by surgical release developed Dupuytren disease (mean, 56.11 days SD, 80.93 days, log-rank P =. See screen capture below: .08.40.36.
![netnewswire 6 netnewswire 6](https://venturebeat.com/wp-content/uploads/2018/05/star-treke284a2_-bridge-crew_20180520211730.jpg)
0005) and the lowest rates of no intervention (n = 103, 0.48%, P =. After adding a new feed, the name is first shown as 'Untitled' until the feeds are refreshed or the application restarted.
![netnewswire 6 netnewswire 6](https://9to5mac.com/wp-content/uploads/sites/6/2021/06/netnewswire-header.jpg)
Furthermore, this cohort had the highest rates of fasciectomy (n = 55, 0.26%, P <. In all, 171 patients in the surgery cohort developed Dupuytren disease 1 year after undergoing surgical trigger finger release. If your work depends on news or you just like being up to date with everything, NetNewsWire does everything an RSS feeder should do and more. 0424) and treatment with fasciectomy (n = 14, 0.07%, P <. Trigger fingers treated by steroid injection only had the lowest rates of Dupuytren disease overall (n = 137, 0.64%, P =. A new Dupuytren diagnosis after trigger finger treatment occurred in 1 in 128 patients overall, 1 in 156 patients treated with steroid injection, and 1 in 126 patients treated with surgical release. The matched population analyzed in this study consisted of 85 944 patients who were equally represented in the steroid injection cohort (n = 21 486, 25.00%), surgical release cohort (n = 21 486, 25.00%), steroids prior to surgery cohort (n = 21 486, 25.00%), and no intervention (control) cohort (n = 21 486, 25.00%). One-to-one exact matching based on baseline patient demographics allowed us to create 4 identical groups defined by the type of trigger finger intervention received. PearlDiver's Mariner 30 database was queried to identify patients with trigger finger between January 2010 and June 2019. Let NetNewsWire do the work for you, as it gathers your news and tells you which. This article compares the rates and time-to-development of new-onset Dupuytren disease in patients with trigger finger treated by steroid injection, surgical release, or both.